Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A prospective trial to evaluate safety and efficacy of hormonal therapies to treat infertility in women with endometriosis

Next Previous
Trial Profile

A prospective trial to evaluate safety and efficacy of hormonal therapies to treat infertility in women with endometriosis

Status: Planning
Phase of Trial: Phase I/II

Latest Information Update: 26 May 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hormones (Primary)
  • Indications Infertility
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 26 May 2016 New trial record
    • 10 Feb 2016 According to a Viramal media release, the company has planned 6 studies in women's health including phase I/II, expected to initiate between Q2 2016 and 2017, subject to funding. The company is in the process of finalizing INDs for the drugs, including products to treat infertility in women with endometriosis and limit side effects of existing therapies, and provide estrogen therapy in multiple formulations for menopausal women.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top